Chemical Works of Gedeon Richter Plc (RGEDF)
38.55
+0.62
(+1.64%)
USD |
OTCM |
Oct 06, 16:00
Chemical Works of Gedeon Richter Price : 38.55 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 37.49 | 38.55 | 37.49 | 38.55 | 8752.00 |
| Oct 05, 2026 | 37.84 | 37.97 | 37.84 | 37.93 | 17.00 |
| Oct 02, 2026 | 38.40 | 38.40 | 38.36 | 38.36 | 17.00 |
| Oct 01, 2026 | 38.41 | 38.41 | 38.41 | 38.41 | 28.00 |
| Sep 30, 2026 | 39.14 | 39.14 | 39.14 | 39.14 | 32.00 |
| Sep 29, 2026 | 37.58 | 38.72 | 37.58 | 38.72 | 108.00 |
| Sep 28, 2026 | 38.80 | 38.87 | 38.80 | 38.87 | 72.00 |
| Sep 25, 2026 | 38.96 | 39.54 | 38.49 | 39.54 | 124.00 |
| Sep 24, 2026 | 39.69 | 39.69 | 38.75 | 38.75 | 84.00 |
| Sep 23, 2026 | 40.95 | 40.95 | 38.92 | 38.92 | 20.00 |
| Sep 22, 2026 | 40.91 | 40.99 | 40.91 | 40.99 | 105.00 |
| Sep 21, 2026 | 41.27 | 41.87 | 41.27 | 41.87 | 520.00 |
| Sep 18, 2026 | 40.99 | 41.02 | 40.99 | 41.02 | 12.00 |
| Sep 17, 2026 | 41.48 | 41.48 | 41.48 | 41.48 | 11.00 |
| Sep 16, 2026 | 40.12 | 40.12 | 40.12 | 40.12 | 30.00 |
| Sep 15, 2026 | 40.48 | 40.48 | 39.30 | 39.30 | 21.00 |
| Sep 14, 2026 | 39.35 | 40.14 | 38.93 | 40.14 | 13.00 |
| Sep 11, 2026 | 40.42 | 40.60 | 39.39 | 39.39 | 156.00 |
| Sep 10, 2026 | 40.11 | 40.96 | 40.11 | 40.96 | 43.00 |
| Sep 09, 2026 | 40.72 | 40.72 | 40.64 | 40.64 | 41.00 |
| Sep 08, 2026 | 42.42 | 42.42 | 40.14 | 40.66 | 20.00 |
| Sep 04, 2026 | 42.79 | 42.79 | 41.34 | 41.38 | 10.00 |
| Sep 03, 2026 | 40.22 | 40.22 | 40.22 | 40.22 | 1.000 |
| Sep 02, 2026 | 40.86 | 40.86 | 40.75 | 40.75 | 35.00 |
| Sep 01, 2026 | 42.03 | 42.18 | 42.03 | 42.18 | 4702.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 159.58 |
| ANI Pharmaceuticals, Inc. | 72.06 |
| Corcept Therapeutics, Inc. | 119.65 |
| Veru, Inc. | 2.48 |
| Avadel Pharmaceuticals Plc | 21.64 |
Price Related Metrics
| PE Ratio | 10.71 |
| PS Ratio | 2.489 |
| PEG Ratio | 0.9871 |
| Price to Book Value | 1.616 |
| Price to Free Cash Flow | 8.729 |
| Earnings Yield | 9.34% |
| Market Cap | 7.058B |
| PEGY Ratio | 0.6525 |
| Operating PE Ratio | 7.028 |
| Normalized PE Ratio | 10.71 |